Skip to main content
OpenTrials
Completed

NCT Number: NCT02454686

Fibroscan Predicts Complications After Hepatectomy

Most of the postoperative complications that may occur after hepatectomy are related to the underlying liver background, and the common preoperative tests do not completely predict such complications. Transient elastography by Fibroscan is used to calculate the stiffness and the steatosis of the liver, and it may be also used to predict postoperative complications after hepatectomy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Neoplasms Digestive System Diseases Digestive System Neoplasms Liver Diseases Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

A prospective cohort study on consecutive patients scheduled for hepatectomy was planned. Fibroscan was performed during the preoperative workup. Accuracy of the liver stiffness and steatosis measured by Fibroscan in predicting the presence of cirrhosis, of steatosis, and the development of postoperative complications was assessed by ROC curve, and multivariate analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with primary and secondary tumors scheduled for hepatectomy at our Unit
  • Written consent to get the Fibroscan during the preoperative workup

Exclusion criteria

  • Refute to get the Fibroscan
  • Loss of data

Treatment and study plan

Primary outcomes

  1. Accuracy of Fibroscan in predicting complication after hepatectomy

    Time frame: 90 days

    Calculation of the accuracy of the liver stiffness and steatosis measured with the Fibroscan in predicting complications after hepatectomy. The values of the stiffness and steatosis will be correlated with the number of complications

Sponsors and collaborators

Lead sponsor

University of Milan

Other

Registry information

Official study title

Role of Fibroscan in Predicting Complications After Hepatectomy

Acronym: Fibroscan

Important dates

Study start
2012
Primary completion
2014
Study completion
2015
First posted
May 27, 2015
Registry last updated
May 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.